Fierce Pharma
JULY 10, 2024
It’s well known that obesity drugs from Novo Nordisk and Eli Lilly are on a high-flying growth trajectory that doesn’t look to be letting up anytime soon. | Novo Nordisk's Ozempic is slated to take over No.1, while Merck's Keytruda falls to No.9 on Evaluate's predicted rankings of top drugs by 2030 sales.
Pharmaceutical Commerce
JULY 10, 2024
In an interview with Pharma Commerce editor Nicholas Saraceno, Peter Ax, UpScriptHealth, founder and CEO, offers his thoughts surrounding the lack of supply.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
JULY 10, 2024
While much of the attention on Novo Nordisk these days revolves around the company’s wildly popular GLP-1 drugs Ozempic and Wegovy, insulin remains a critical backbone for the drugmaker. | As Novo Nordisk steadily ups its commitments in Asia, the company is teaming up with Indonesia’s state-owned pharmaceutical firm Bio Farma to bolster insulin packaging in the southeast Asian nation.
ALULA
JULY 10, 2024
Earlier this year, I had the pleasure of giving an invited talk at the Organizational Behavior Management ( OBM ) Network Conference in Houston, TX. I knew it would be a great opportunity to engage with OBM professionals and researchers on a challenge that everyone shares right now: facing the inevitability of change, particularly career change.
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
Fierce Pharma
JULY 10, 2024
Editor's note: This story was corrected to note that Brooks will be Eli Lilly's interim CFO. | Gordon Brooks, currently Eli Lilly's group vice president, controller and corporate strategy, will take the interim role after 29 years at the drugmaker.
PharmaVoice
JULY 10, 2024
The company has begun searching for a successor to Dolsten, who oversaw more than 35 drug and vaccine approvals alongside notable setbacks during his time as Pfizer’s top scientist.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
MaBiCo
JULY 10, 2024
Medical Sales Rep Recruitment (Part 2): How to optimize the hiring process to select top talent. In our previous article, we explored the fundamental steps necessary for implementing an effective medical representative selection process. These steps included identifying key characteristics exhibited by top-performing salespeople and using them as benchmarks for hiring.
Fierce Pharma
JULY 10, 2024
Pharmaceutical CEOs often earn pay packages worth tens of millions of dollars for leading the top drugmaking companies in the industry. | In this week's episode of "The Top Line," Fierce Pharma’s Eric Sagonowsky and Fraiser Kansteiner discuss Fierce’s annual special report, “Big Pharma's 10 highest-paid CEOs.
MedCity News
JULY 10, 2024
CMS issued its proposed rule for next year’s Medicare physician fee schedule, revealing plans to cut payment rates by 2.8%. Industry groups swiftly expressed their outrage, arguing that reimbursement rates need to keep up with the pace of inflation. The post Why Industry Groups Are Decrying CMS’ Physician Fee Schedule Proposal appeared first on MedCity News.
pharmaphorum
JULY 10, 2024
After short but worrying delay, Arcutis gets FDA approval for flagship drug Zoryve in atopic dermatitis, which could further unlock sales growth
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
MedCity News
JULY 10, 2024
Is it possible to be pro-human and pro-tech at the same time when it comes to our healthcare? The post “Robotic-based” Home Care is Actually More … Human appeared first on MedCity News.
Pharmaceutical Technology
JULY 10, 2024
Almirall’s Ebglyss is predicted to hit blockbuster status in two years in the crowded atopic dermatitis market.
MedCity News
JULY 10, 2024
Hospitals would be much better served by focusing on reuse and reprocessing programs. So why isn’t that happening and what can be done about it? The post Medical Device Recycling Programs Are Manufacturer Money-Grabs Disguised as Sustainability Initiatives appeared first on MedCity News.
PharmaTimes
JULY 10, 2024
Around one in five dementia hospitalisations are due to potentially preventable causes
Advertisement
Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten
MedCity News
JULY 10, 2024
Unlike GLP-1 agonist drugs marketed for weight loss, new Amylyx Pharmaceuticals drug avexitide blocks its target receptor. Amylyx plans to advance this GLP-1 antagonist into Phase 3 testing for post-bariatric hypoglycemia, a rare condition in which blood sugar levels drop precipitously. The post Amylyx Aims to Help Patients With a Novel GLP-1 Drug, But Not the Way You Think appeared first on MedCity News.
Pharmaceutical Technology
JULY 10, 2024
Evotec and Pfizer have entered a multi-year partnership that will focus initially on early discovery research.
Pharmaceutical Commerce
JULY 10, 2024
Why these programs require a hybrid approach that combines technology and human connection.
pharmaphorum
JULY 10, 2024
Shares in Dutch biotech uniQure shoot up after Huntington’s candidate AMT-130 slows disease progression by 80% two years after dosing.
Clarivate
JULY 10, 2024
Summary: Older research often presents fresh opportunities to advance scientific and scholarly research today. Learn more about a few notable examples. Staying up to date with the newest findings in a field is critical in today’s fast-paced research environment. Researchers need to ensure that they are pursuing novel ideas and incorporating the most recent evidence in their work.
PharmaTimes
JULY 10, 2024
The neurodegenerative condition currently affects more than 944,000 people in the UK
MedCity News
JULY 10, 2024
A new partnership will give Hello Alpha patients access to Phenomix Sciences’ genetic obesity test. The post Hello Alpha, Phenomix Sciences Launch Partnership for Genetic Obesity Test appeared first on MedCity News.
Pharmaceutical Commerce
JULY 10, 2024
The latest news for pharma industry insiders.
Advertisement
Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.
Pharmatutor
JULY 10, 2024
Serum : Effective mode with high concentration of actives Pradip Mahajan Thu, 07/11/2024 - 11:47 Vinay Kumar Singh. Head-Formulation Kumar Organic Products Research Centre Pvt. Ltd., Bengaluru Email : formulation_krc@kopresearchcentre.
PharmaTech
JULY 10, 2024
The acquisition of uniQure’s Lexington, Mass., manufacturing operations will boost Genezen’s late-phase and commercial gene therapy development and manufacturing services.
Pharmaceutical Technology
JULY 10, 2024
IntegriChain, a provider of data-driven commercialisation solutions for the pharma industry, has acquired Federal Compliance Solutions (FCS).
PharmExec
JULY 10, 2024
Zoryve is a steroid-free, once-daily treatment shown to offer rapid disease clearance and significant itch reduction for patients with mild to moderate atopic dermatitis.
Pharmaceutical Technology
JULY 10, 2024
Lomecel-B is also being investigated for treating hypoplastic left heart syndrome, and ageing-related frailty, in addition to Alzheimer’s.
PharmaVoice
JULY 10, 2024
As more Americans take obesity medications, adjacent businesses are offering supportive services to offset side effects, collect data and foster new health benefits.
pharmaphorum
JULY 10, 2024
NICE backs monthly eczema drug from Almirall Phil.
Pharmaceutical Technology
JULY 10, 2024
Pint Pharma has announced the approval of Orladeyo (berotralstat) in Peru to prevent hereditary angioedema (HAE) attacks.
Advertisement
Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A
Expert insights. Personalized for you.
277 
Let's personalize your content